Form 4 for HROW HARROW, INC.
Accepted 2024-09-13 00:00:00 ET · period of report 2024-09-11 · accession 0001493152-24-036244 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-13 | 2024-09-11 | HROW | SAHAREK JOHN P. | CEO of ImprimisRx | M - OptEx | $7.37 | +90.0K | 344.8K | +35% | +$663.3K |
| D | 2024-09-13 | 2024-09-11 | HROW | SAHAREK JOHN P. | CEO of ImprimisRx | F - Tax | $41.37 | -45.1K | 299.7K | -13% | -$1.87M |
| D | 2024-09-13 | 2024-09-11 | HROW | SAHAREK JOHN P. | CEO of ImprimisRx | M - OptEx | $0.00 | -90.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-09-11 | M | A | 90,000 | $7.37 | 344,803 | D | — | — | |
| 2 | Common | Common stock | 2024-09-11 | F | D | 45,140 | $41.37 | 299,663 | D | — | — | (F1) The stock option was granted on February 1, 2015 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of February 1, 2025. 29,107 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident and 16,033 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's cost to purchase the stock option. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-09-11 | M | D | 90,000 | $0.00 | 0 | D | $7.37 · — to 2025-02-01 | 90,000 Common Stock | (F1) The stock option was granted on February 1, 2015 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of February 1, 2025. 29,107 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's payroll tax liability incident and 16,033 shares of Harrow common stock listed as disposed were withheld from issuance by Harrow to satisfy Mr. Saharek's cost to purchase the stock option. |